Non-HLA Antibodies in Kidney Transplantation: Mediators of Allograft Injury or Markers of Dysregulated Humoral Immunity? [PDF]
Fouza A, Daoudaki M.
europepmc +1 more source
Characterisation of a New HLA Allele by Next-Generation Sequencing: HLA-C*06:424Q. [PDF]
Balakrishnan G +4 more
europepmc +1 more source
Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential. [PDF]
Virk UY +5 more
europepmc +1 more source
Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy. [PDF]
Cho S, Lee J, Lee YM, Nam JH.
europepmc +1 more source
Triple-negative breast cancer, pregnancy, and HLA alloreactivity: a cause for concern? [PDF]
Crestani Morassutti G, Zanetti M.
europepmc +1 more source
Recommendations From the Implementation Steering Group for Organ Utilisation Histocompatibility and Immunogenetics Sub-Group: ISOU H&I Sub-Group Recommendations. [PDF]
Speirs NC +14 more
europepmc +1 more source
Characterisation of the Novel HLA-B*51:01:01:126 Allele in a Greek Renal Transplant Candidate. [PDF]
Kouniaki D, Nikolaou S, Tsirogianni A.
europepmc +1 more source
The Novel HLA-C*01:02:01:78 Allele Identified in a Greek Haematopoietic Stem Cell Donor. [PDF]
Kouniaki D, Kitsiou V, Tsirogianni A.
europepmc +1 more source
The Novel Allele, HLA-C*14:167, With a Non-Synonymous Mutation in Exon 1. [PDF]
Kouniaki D +2 more
europepmc +1 more source
Minor histocompatibility antigen TCR-T. [PDF]
Krakow EF, Bleakley M.
europepmc +1 more source

